Zepbound (tirzepatide) is a once-weekly subcutaneous injection approved by the FDA for chronic weight management in adults with obesity or overweight with at least one weight-related comorbid condition
(2019), the genome of V
CntA/B is a notoriously hard enzyme to study, but once it was stabilized, we were able to gain insight into how CntA perceives its L-carnitine substrate with a 3D crystal structure model, and by studying the complete electron transfer pathway, we could see how the protein is able to turn over TMA
For some people, they may play an important medical role
GLP-1s are most effective for weight loss when paired with support in other areas, including guidance on nutrition, physical activity and mental health
In type 2 diabetes, the incretin effect is diminished and in parallel, post-prandial insulin secretion is deteriorating (2, 5)